Evidence map›Paper›PMID 39554190›Full record

ArticlebioRxiv : the preprint server for biology2025

A Structural Mechanism for Noncanonical GPCR Signal Transduction in the Hedgehog Pathway.

William P Steiner, Nathan Iverson, Guibing Liu, Varun Venkatakrishnan, Jian Wu, Tomasz Maciej Stepniewski, Zachary Michaelson, Jan W Bröckel, Ju-Fen Zhu, Jessica Bruystens and 16 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

William P SteinerDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0009-0009-5605-1847
Nathan IversonDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Guibing LiuDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Varun VenkatakrishnanDepartment of Chemistry, Pennsylvania State University, University Park, PA, USA.ORCID 0000-0002-7169-1684
Jian WuDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Tomasz Maciej StepniewskiResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM) - Pompeu Fabra University (UPF), Dr Aiguader 88, Barcelona, Spain.ORCID 0000-0002-6828-9192
Zachary MichaelsonDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Jan W BröckelInstitute for Biology, Department of Biochemistry, University of Kassel, Kassel, Germany.
Ju-Fen ZhuDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Jessica BruystensDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Annabel LeeDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Isaac NelsonDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Daniela BertinettiInstitute for Biology, Department of Biochemistry, University of Kassel, Kassel, Germany.
Corvin D ArvesethDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0003-1769-1162
Gerald TanDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Paul SpaltensteinDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0003-0476-7287
Jiewei XuDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.
Ruth HüttenhainDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-0896-5910
Michael KayDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Friedrich W HerbergInstitute for Biology, Department of Biochemistry, University of Kassel, Kassel, Germany.ORCID 0000-0001-7117-7653
Erhu CaoDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Jana SelentResearch Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM) - Pompeu Fabra University (UPF), Dr Aiguader 88, Barcelona, Spain.ORCID 0000-0002-1844-4449
Ganesh S AnandDepartment of Chemistry, Pennsylvania State University, University Park, PA, USA.
Roland L DunbrackInstitute for Cancer Research. Fox Chase Cancer Center. Philadelphia PA, USA.ORCID 0000-0001-7674-6667
Susan S TaylorDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-7702-6108
Benjamin R MyersDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0003-0975-539X

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Michael S Kay · 2022 to 2026
$34.4M
Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer BiologyR35GM122517 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI ROLAND L DUNBRACK · 2017 to 2026
$6.3M
Lessons Learned from PKA: Assembly of Dynamic Macromolecular SwitchesR35GM130389 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN S. TAYLOR · 2019 to 2026
$5.7M
Signal Transduction in the Primary Cilium: Hedgehog and BeyondR35GM133672 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Benjamin Myers · 2019 to 2026
$3.1M
Morphogenetic signaling from the cell surface to the nucleus during vertebrate eye developmentR01EY035377 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Kristen M Kwan, Benjamin Myers · 2024 to 2026
$2.0M
Program for Interdisciplinary Training in CHemical BiologyT32GM122740 · NIGMS · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2018 to 2022
$932k
NCI NIH HHS P30 CA006927NCI NIH HHS T32 CA009523NEI NIH HHS R01 EY035377NIAID NIH HHS U54 AI170856NIGMS NIH HHS R35 GM122517NIGMS NIH HHS R35 GM130389NIGMS NIH HHS R35 GM133672NIGMS NIH HHS T32 GM122740
6 · The paper itself

Abstract

The Hedgehog (Hh) signaling pathway is fundamental to embryogenesis, tissue homeostasis, and cancer. Hh signals are transduced via an unusual mechanism: upon agonist-induced phosphorylation, the noncanonical G protein-coupled receptor SMOOTHENED (SMO) binds the catalytic subunit of protein kinase A (PKA-C) and physically blocks its enzymatic activity. By combining computational structural approaches with biochemical and functional studies, we show that SMO mimics strategies prevalent in canonical GPCR and PKA signaling complexes, despite little sequence or secondary structural homology. An intrinsically disordered region of SMO binds the PKA-C active site, resembling the PKA regulatory subunit (PKA-R) / PKA-C holoenzyme, while the SMO transmembrane domain binds a conserved PKA-C interaction hub, similar to other GPCR-effector complexes. In contrast with prevailing GPCR signal transduction models, phosphorylation of SMO promotes intramolecular electrostatic interactions that stabilize key structural elements within the SMO cytoplasmic domain, thereby remodeling it into a PKA-inhibiting conformation. Our work provides a structural mechanism for a central step in the Hh cascade and defines a paradigm for disordered GPCR domains to transmit signals intracellularly.

Identifiers

PMID39554190
PMCPMC11565934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.